Dr. Martens plc (LON:DOCS - Get Free Report)'s stock price traded up 25.8% during trading on Thursday . The company traded as high as GBX 76 ($1.03) and last traded at GBX 75.40 ($1.02). 8,364,149 shares were traded during mid-day trading, an increase of 271% from the average session volume of 2,253,765 shares. The stock had previously closed at GBX 59.95 ($0.81).
Wall Street Analyst Weigh In
Separately, Royal Bank of Canada reduced their price objective on Dr. Martens from GBX 7,000 ($95.06) to GBX 6,000 ($81.48) and set a "sector perform" rating for the company in a report on Monday, May 19th.
Check Out Our Latest Report on Dr. Martens
Dr. Martens Price Performance
The stock has a market cap of £795.54 million, a P/E ratio of 11.62, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11. The company has a quick ratio of 1.13, a current ratio of 2.85 and a debt-to-equity ratio of 127.27. The business's 50-day simple moving average is GBX 54.73 and its two-hundred day simple moving average is GBX 62.64.
Dr. Martens (LON:DOCS - Get Free Report) last announced its quarterly earnings results on Thursday, June 5th. The company reported GBX 2.40 ($0.03) EPS for the quarter. Dr. Martens had a net margin of 7.89% and a return on equity of 18.91%. Sell-side analysts expect that Dr. Martens plc will post 2.5809394 EPS for the current year.
Dr. Martens Cuts Dividend
The business also recently disclosed a dividend, which was paid on Tuesday, April 8th. Investors of record on Thursday, March 6th were paid a dividend of GBX 0.85 ($0.01) per share. The ex-dividend date of this dividend was Thursday, March 6th. This represents a dividend yield of 1.47%. Dr. Martens's payout ratio is 42.53%.
Insiders Place Their Bets
In other news, insider Giles Wilson purchased 32,640 shares of Dr. Martens stock in a transaction dated Tuesday, March 25th. The stock was purchased at an average cost of GBX 54 ($0.73) per share, for a total transaction of £17,625.60 ($23,934.82). Insiders purchased a total of 33,206 shares of company stock worth $1,792,771 in the last quarter. 4.36% of the stock is owned by company insiders.
Dr. Martens Company Profile
(
Get Free Report)
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
Recommended Stories
Before you consider Dr. Martens, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dr. Martens wasn't on the list.
While Dr. Martens currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
